Lumos Diagnostics Holdings Limited
LDXHF
$0.115
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -3.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -3.36% | |||
| Cost of Revenue | 0.00% | 28.40% | |||
| Gross Profit | 0.00% | -18.85% | |||
| SG&A Expenses | 0.00% | 8.36% | |||
| Depreciation & Amortization | 0.00% | -11.90% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 9.42% | |||
| Operating Income | 0.00% | -32.67% | |||
| Income Before Tax | 0.00% | -56.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | -56.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -56.17% | |||
| EBIT | 0.00% | -32.67% | |||
| EBITDA | -8.78% | -86.02% | |||
| EPS Basic | 0.00% | -26.09% | |||
| Normalized Basic EPS | 0.00% | -28.57% | |||
| EPS Diluted | 0.00% | -26.09% | |||
| Normalized Diluted EPS | 0.00% | -28.57% | |||
| Average Basic Shares Outstanding | 0.00% | 21.93% | |||
| Average Diluted Shares Outstanding | 0.00% | 21.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||